{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:39:23Z","timestamp":1786991963356,"version":"build-2736575974"},"reference-count":110,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100016868","name":"University of Minnesota Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016868","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007249","name":"University of Minnesota","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007249","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007093","name":"Richard M. Schulze Family Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007093","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013187","name":"Randy Shaver Cancer Research and Community Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013187","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.jcv.2025.105854","type":"journal-article","created":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T06:46:52Z","timestamp":1754635612000},"page":"105854","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Epstein-Barr virus (EBV) infection and its sequelae in the immunocompetent host"],"prefix":"10.1016","volume":"180","author":[{"given":"Madeline R.","family":"Meirhaeghe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9376-4365","authenticated-orcid":false,"suffix":"Jr.","given":"Henry H.","family":"Balfour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcv.2025.105854_bib1","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0140-6736(64)91524-7","article-title":"Virus particles in cultured lymphoblasts from Burkitt's lymphoma","volume":"1","author":"Epstein","year":"1964","journal-title":"Lancet"},{"key":"10.1016\/j.jcv.2025.105854_bib2","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1073\/pnas.59.1.94","article-title":"Relation of Burkitt's tumor-associated herpes-type virus to infectious mononucleosis","volume":"59","author":"Henle","year":"1968","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jcv.2025.105854_bib3","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1136\/bmj.325.7373.1128","article-title":"Infection as a cause of multiple sclerosis","volume":"325","author":"Murray","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.jcv.2025.105854_bib4","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1126\/science.abj8222","article-title":"Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis","volume":"375","author":"Bjornevik","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.jcv.2025.105854_bib5","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41586-022-04432-7","article-title":"Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM","volume":"603","author":"Lanz","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.jcv.2025.105854_bib6","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/1097-0142(197102)27:2<416::AID-CNCR2820270227>3.0.CO;2-W","article-title":"Elevated antibody titers to Epstein-Barr virus in Hodgkin's disease","volume":"27","author":"Levine","year":"1971","journal-title":"Cancer"},{"key":"10.1016\/j.jcv.2025.105854_bib7","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1056\/NEJMoa023141","article-title":"Characteristics of Hodgkin's lymphoma after infectious mononucleosis","volume":"349","author":"Hjalgrim","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jcv.2025.105854_bib8","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1073\/pnas.56.6.1699","article-title":"Precipitating antibody in human serum to an antigen present in cultured burkitt's lymphoma cells","volume":"56","author":"Old","year":"1966","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jcv.2025.105854_bib9","first-page":"3","article-title":"Sero-epidemiology of the Epstein-Barr virus: preliminary analysis of an international study - a review","author":"de-The","year":"1975","journal-title":"IARC Sci. Publ."},{"key":"10.1016\/j.jcv.2025.105854_bib10","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1093\/infdis\/jit321","article-title":"Age-specific prevalence of Epstein-Barr virus infection among individuals aged 6-19 years in the United States and factors affecting its acquisition","volume":"208","author":"Balfour","year":"2013","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jcv.2025.105854_bib11","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/cid\/ciu342","article-title":"Age-specific prevalence of Epstein-Barr virus infection among Minnesota children: effects of race\/ethnicity and family environment","volume":"59","author":"Condon","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jcv.2025.105854_bib12","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/infdis\/jis646","article-title":"Behavioral, virologic, and immunologic factors associated with acquisition and severity of primary Epstein-Barr virus infection in university students","volume":"207","author":"Balfour","year":"2013","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jcv.2025.105854_bib13","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1086\/342596","article-title":"Sexual history and Epstein-Barr virus infection","volume":"186","author":"Crawford","year":"2002","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jcv.2025.105854_bib14","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1182\/blood.V87.2.812.bloodjournal872812","article-title":"Epstein-Barr virus transmission from a blood donor to an organ transplant recipient with recovery of the same virus strain from the recipient's blood and oropharynx","volume":"87","author":"Alfieri","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.jcv.2025.105854_bib15","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1097\/TP.0000000000000490","article-title":"Valganciclovir administration to kidney donors to reduce the burden of cytomegalovirus and Epstein-Barr virus transmission during transplantation","volume":"99","author":"Verghese","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.jcv.2025.105854_bib16","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1001\/jama.1981.03320140067034","article-title":"In utero Epstein-Barr virus (infectious mononucleosis) infection","volume":"246","author":"Goldberg","year":"1981","journal-title":"JAMA"},{"key":"10.1016\/j.jcv.2025.105854_bib17","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1093\/infdis\/jiv290","article-title":"Breast milk as a potential source of Epstein-Barr virus transmission among infants living in a malaria-endemic region of Kenya","volume":"212","author":"Daud","year":"2015","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jcv.2025.105854_bib18","doi-asserted-by":"crossref","DOI":"10.1038\/cti.2016.28","article-title":"Epstein-Barr virus dynamics in asymptomatic immunocompetent adults: an intensive 6-month study","volume":"5","author":"Johnson","year":"2016","journal-title":"Clin. Transl. Immunol."},{"key":"10.1016\/j.jcv.2025.105854_bib19","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1172\/JCI32377","article-title":"HLA class I polymorphisms are associated with development of infectious mononucleosis upon primary EBV infection","volume":"117","author":"McAulay","year":"2007","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.jcv.2025.105854_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012496","article-title":"An updated meta-analysis of risk of multiple sclerosis following infectious mononucleosis","volume":"5","author":"Handel","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jcv.2025.105854_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.991069","article-title":"Risk of malignancy following exposure to Epstein-Barr virus associated infectious mononucleosis: a nationwide population-based cohort study","volume":"12","author":"Cai","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jcv.2025.105854_bib22","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.4143\/crt.2023.1356","article-title":"The impact of infectious mononucleosis history on the risk of developing lymphoma and nasopharyngeal carcinoma: a retrospective large-scale cohort study using national health insurance data in South Korea","volume":"56","author":"Kang","year":"2024","journal-title":"Cancer Res. Treat."},{"key":"10.1016\/j.jcv.2025.105854_bib23","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/00000441-195503000-00003","article-title":"The transmission of infectious mononucleosis","volume":"229","author":"Hoagland","year":"1955","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/j.jcv.2025.105854_bib24","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/0090-1229(84)90029-1","article-title":"Virologic, immunologic, and clinical observations on a patient during the incubation, acute, and convalescent phases of infectious mononucleosis","volume":"30","author":"Svedmyr","year":"1984","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.jcv.2025.105854_bib25","doi-asserted-by":"crossref","DOI":"10.1038\/cti.2016.48","article-title":"Prospective studies of infectious mononucleosis in university students","author":"Grimm","year":"2016","journal-title":"Clin. Transl. Immunol."},{"key":"10.1016\/j.jcv.2025.105854_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005286","article-title":"The incubation period of primary Epstein-Barr virus infection: viral dynamics and immunologic events","volume":"11","author":"Dunmire","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.jcv.2025.105854_bib27","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1182\/blood.V57.5.933.933","article-title":"Clinical and laboratory evaluation of infants and children with Epstein-Barr virus-induced infectious mononucleosis: report of 32 patients (aged 10-48 months)","volume":"57","author":"Horwitz","year":"1981","journal-title":"Blood"},{"key":"10.1016\/j.jcv.2025.105854_bib28","first-page":"166","article-title":"Burkitt\u2019s lymphoma in Africa, a review of the epidemiology and etiology","volume":"7","author":"Orem","year":"2007","journal-title":"Afr. Health Sci."},{"key":"10.1016\/j.jcv.2025.105854_bib29","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1750-9378-8-35","article-title":"Burkitt lymphoma: beyond discoveries","volume":"8","author":"Mbulaiteye","year":"2013","journal-title":"Infect. Agent Cancer"},{"key":"10.1016\/j.jcv.2025.105854_bib30","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/bjs.18004619704","article-title":"A sarcoma involving the jaws in African children","volume":"46","author":"Burkitt","year":"1958","journal-title":"Br. J. Surg."},{"key":"10.1016\/j.jcv.2025.105854_bib31","series-title":"Epstein-Barr Virus","author":"Robertson","year":"2005"},{"key":"10.1016\/j.jcv.2025.105854_bib32","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0065-230X(08)60470-4","article-title":"The pathogenesis of Burkitt\u2019s lymphoma","volume":"55","author":"Magrath","year":"1990","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.jcv.2025.105854_bib33","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/00043426-199122000-00019","article-title":"African burkitt\u2019s lymphoma. History, biology, clinical features, and treatment","volume":"13","author":"Magrath","year":"1991","journal-title":"Am. J. Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.jcv.2025.105854_bib34","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1182\/blood.V77.5.1092.1092","article-title":"Epstein-Barr virus infection precedes clonal expansion in Burkitt\u2019s and acquired immunodeficiency syndrome-associated lymphoma","volume":"77","author":"Neri","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.jcv.2025.105854_bib35","first-page":"1397","article-title":"Epstein-Barr virus and Burkitt lymphoma","volume":"60","author":"Brady","year":"2007","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.jcv.2025.105854_bib36","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1750-9378-9-34","article-title":"The role of EBV in the pathogenesis of burkitt\u2019s lymphoma: an Italian hospital based survey","volume":"9","author":"Pannone","year":"2014","journal-title":"Infect. Agent Cancer"},{"issue":"24","key":"10.1016\/j.jcv.2025.105854_bib37","doi-asserted-by":"crossref","first-page":"14269","DOI":"10.1073\/pnas.2336099100","article-title":"Epstein-Barr virus provides a survival factor to Burkitt\u2019s lymphomas","volume":"100","author":"Kennedy","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jcv.2025.105854_bib38","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ebiom.2018.12.041","article-title":"Epstein-Barr virus, malaria and endemic Burkitt lymphoma","volume":"39","author":"Velavan","year":"2018","journal-title":"eBioMedicine"},{"key":"10.1016\/j.jcv.2025.105854_bib39","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.coviro.2016.09.006","article-title":"Malaria \u2013 how this parasitic infection aids and abets EBV-associated burkitt lymphomagenesis","volume":"20","author":"Moormann","year":"2016","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.jcv.2025.105854_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004170","article-title":"A multifactorial role for P. falciparum malaria in endemic Burkitt\u2019s lymphoma pathogenesis","volume":"10","author":"Torgbor","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.jcv.2025.105854_bib41","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.jcv.2025.105854_bib42","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.semradonc.2009.09.006","article-title":"Hodgkin lymphoma across the age spectrum: epidemiology, therapy, and late effects","volume":"20","author":"Punnett","year":"2010","journal-title":"Semin. Radiat. Oncol."},{"key":"10.1016\/j.jcv.2025.105854_bib43","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/s41375-021-01204-6","article-title":"Molecular biology of Hodgkin lymphoma","volume":"35","author":"Weniger","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.jcv.2025.105854_bib44","first-page":"86","article-title":"Epstein-Barr viral DNA in tissues of Hodgkin\u2019s disease","volume":"129","author":"Weiss","year":"1987","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jcv.2025.105854_bib45","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1056\/NEJM198902233200806","article-title":"Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin\u2019s disease","volume":"320","author":"Weiss","year":"1989","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jcv.2025.105854_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ajcp\/91.1.1","article-title":"A survey of Epstein-Barr virus DNA in lymphoid tissue. Frequent detection in Hodgkin's disease","volume":"91","author":"Staal","year":"1989","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.jcv.2025.105854_bib47","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3109\/10428199409051664","article-title":"Detection of Epstein-Barr virus DNA in Hodgkin- and Reed-Sternberg-cells by single cell PCR","volume":"13","author":"Roth","year":"1994","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.jcv.2025.105854_bib48","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/ijc.2910460509","article-title":"Detection of EBV gene expression in Reed-Sternberg cells of Hodgkin's disease","volume":"46","author":"Wu","year":"1990","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jcv.2025.105854_bib49","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s10238-024-01524-8","article-title":"Hodgkin lymphoma: the role of EBV plasma viral load testing in an HIV-endemic setting","volume":"25","author":"Opie","year":"2025","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.jcv.2025.105854_bib50","article-title":"EBV in Hodgkin lymphoma","volume":"1","author":"Massini","year":"2009","journal-title":"Mediterr. J. Hematol. Infect. Dis."},{"issue":"1","key":"10.1016\/j.jcv.2025.105854_bib51","first-page":"S74","article-title":"Identifying the precursors of Hodgkin and Reed-Sternberg cells in Hodgkin\u2019s disease: role of the germinal center in B-cell lymphomagenesis","volume":"21","author":"K\u00fcppers","year":"1999","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.jcv.2025.105854_bib52","doi-asserted-by":"crossref","first-page":"4766","DOI":"10.1073\/pnas.88.11.4766","article-title":"Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells","volume":"88","author":"Herbst","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jcv.2025.105854_bib53","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1084\/jem.177.2.339","article-title":"Epstein-Barr virus and Hodgkin\u2019s disease: transcriptional analysis of virus latency in the malignant cells","volume":"177","author":"Deacon","year":"1993","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jcv.2025.105854_bib54","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1056\/NEJMra032015","article-title":"Persistence of the Epstein-Barr virus and the origins of associated lymphomas","volume":"350","author":"Thorley-Lawson","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jcv.2025.105854_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102613","article-title":"Global, regional, and national epidemiology of nasopharyngeal carcinoma in middle-aged and elderly patients from 1990 to 2021","volume":"104","author":"Liu","year":"2025","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.jcv.2025.105854_bib56","doi-asserted-by":"crossref","DOI":"10.2196\/49968","article-title":"Nasopharyngeal cancer incidence and mortality in 185 countries in 2020 and the projected burden in 2040: population-based global epidemiological profiling","volume":"9","author":"Zhang","year":"2023","journal-title":"JMIR Public Health Surveill."},{"key":"10.1016\/j.jcv.2025.105854_bib57","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1158\/1055-9965.EPI-20-1702","article-title":"The evolving epidemiology of nasopharyngeal carcinoma","volume":"30","author":"Chang","year":"2021","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.jcv.2025.105854_bib58","doi-asserted-by":"crossref","first-page":"1116143","DOI":"10.3389\/fmicb.2023.1116143","article-title":"The role of Epstein-Barr virus in nasopharyngeal carcinoma","volume":"14","author":"Su","year":"2023","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.jcv.2025.105854_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ijc.2910170102","article-title":"Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma","volume":"17","author":"Henle","year":"1976","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jcv.2025.105854_bib60","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/jmv.27440","article-title":"Cell-free E.B.V. DNA as a biomarker during clinical management of nasopharyngeal carcinoma in a nonendemic region","volume":"94","author":"Pramanik","year":"2022","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.jcv.2025.105854_bib61","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/path.5249","article-title":"Plasma Epstein-Barr virus DNA as an archetypal circulating tumour DNA marker","volume":"247","author":"Lam","year":"2019","journal-title":"J. Pathol."},{"key":"10.1016\/j.jcv.2025.105854_bib62","first-page":"26","article-title":"Epidemiology of gastric cancer: global trends, risk factors and prevention","volume":"14","author":"Rawla","year":"2019","journal-title":"Prz. Gastroenterol."},{"key":"10.1016\/j.jcv.2025.105854_bib63","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.canlet.2020.09.019","article-title":"Epstein\u2013Barr virus-associated gastric cancer: a distinct subtype","volume":"495","author":"Yang","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jcv.2025.105854_bib64","first-page":"377","article-title":"Lymphoepithelial carcinoma of the stomach with Epstein-Barr virus demonstrated by polymerase chain reaction","volume":"3","author":"Burke","year":"1990","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.jcv.2025.105854_bib65","first-page":"769","article-title":"Epstein-Barr virus-associated gastric adenocarcinoma","volume":"140","author":"Shibata","year":"1992","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jcv.2025.105854_bib66","first-page":"1431250","article-title":"Epstein-Barr virus in gastric carcinoma","author":"Tokunaga","year":"1993","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jcv.2025.105854_bib67","doi-asserted-by":"crossref","first-page":"9131","DOI":"10.1073\/pnas.91.19.9131","article-title":"Gastric carcinoma: monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein","volume":"91","author":"Imai","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"167","key":"10.1016\/j.jcv.2025.105854_bib68","article-title":"Clinical importance of Epstein\u2013Barr virus-associated gastric cancer","volume":"10","author":"Nishikawa","year":"2018","journal-title":"Cancers"},{"key":"10.1016\/j.jcv.2025.105854_bib69","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00432-021-03824-y","article-title":"Estimating the global burden of Epstein\u2013Barr virus-related cancers","volume":"148","author":"Wong","year":"2022","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.jcv.2025.105854_bib70","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1128\/CMR.00011-10","article-title":"Helicobacter pylori and gastric cancer: factors that modulate disease risk","volume":"23","author":"Wroblewski","year":"2010","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.jcv.2025.105854_bib71","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0062850","article-title":"Epstein Barr virus and Helicobacter pylori Co-Infection are positively associated with severe gastritis in pediatric patients","volume":"8","author":"C\u00e1rdenas-Mondrag\u00f3n","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1016\/j.jcv.2025.105854_bib72","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1038\/bjc.2015.175","article-title":"Case\u2013control study of Epstein\u2013Barr virus and Helicobacter pylori serology in Latin American patients with gastric disease","volume":"112","author":"C\u00e1rdenas-Mondrag\u00f3n","year":"2015","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jcv.2025.105854_bib73","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3390\/pathogens9020104","article-title":"Epstein-Barr virus and Helicobacter pylori co-infection in non-malignant gastroduodenal disorders","volume":"9","author":"D\u00e1vila-Collado","year":"2020","journal-title":"Pathogens"},{"key":"10.1016\/j.jcv.2025.105854_bib74","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1177\/1352458520970841","article-title":"Rising prevalence of multiple sclerosis worldwide: insights from the Atlas of MS (third edition)","volume":"26","author":"Walton","year":"2020","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jcv.2025.105854_bib75","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/ana.20820","article-title":"Infectious mononucleosis and risk for multiple sclerosis: a meta-analysis","volume":"59","author":"Thacker","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jcv.2025.105854_bib76","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1001\/archneur.64.1.72","article-title":"Multiple sclerosis after infectious mononucleosis","volume":"64","author":"Nielsen","year":"2007","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jcv.2025.105854_bib77","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/ana.21117","article-title":"Environmental risk factors for multiple sclerosis. Part I: the role of infection","volume":"61","author":"Ascherio","year":"2007","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jcv.2025.105854_bib78","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1136\/jnnp-2020-322941","article-title":"German competence network multiple sclerosis (KKNMS), other members of the KKNMS that acted as collaborators in this study. Complete Epstein-Barr virus seropositivity in a large cohort of patients with early multiple sclerosis","volume":"91","author":"Abrahamyan","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jcv.2025.105854_bib79","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0029819","article-title":"Multiple sclerosis risk variant HLA-DRB1*1501 associates with high expression of DRB1 gene in different human populations","volume":"7","author":"Alcina","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jcv.2025.105854_bib80","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s40120-017-0086-4","article-title":"Vitamin D and multiple sclerosis: a comprehensive review","volume":"7","author":"Sintzel","year":"2017","journal-title":"Neurol. Ther."},{"key":"10.1016\/j.jcv.2025.105854_bib81","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.molmed.2019.11.003","article-title":"Epstein-Barr virus in multiple sclerosis: theory and emerging immunotherapies","volume":"26","author":"Bar-Or","year":"2020","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.jcv.2025.105854_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.104007","article-title":"EBV as the \u201cgluten of MS\u201d hypothesis provides a rationale for trialing antiviral therapies","volume":"64","author":"Drosu","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.jcv.2025.105854_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.103087","article-title":"Probing the association between multiple sclerosis and Epstein Barr virus from a therapeutic perspective","volume":"52","author":"Drosu","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.jcv.2025.105854_bib84","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/s41588-018-0102-3","article-title":"Transcription factors operate across disease loci, with EBNA2 implicated in autoimmunity","volume":"50","author":"Harley","year":"2018","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jcv.2025.105854_bib85","doi-asserted-by":"crossref","first-page":"6599","DOI":"10.4049\/jimmunol.174.11.6599","article-title":"EBV and systemic lupus erythematosus: a new perspective","volume":"174","author":"Gross","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.jcv.2025.105854_bib86","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/jid.2013.423","article-title":"Epstein-Barr virus infection induces aberrant TLR activation pathway and fibroblast-myofibroblast conversion in scleroderma","volume":"134","author":"Farina","year":"2014","journal-title":"J. Investig. Dermatol."},{"key":"10.1016\/j.jcv.2025.105854_bib87","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/ar1893","article-title":"Epstein\u2013Barr virus and rheumatoid arthritis: is there a link?","volume":"8","author":"Costenbader","year":"2006","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jcv.2025.105854_bib88","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.650713","article-title":"Altered antibody response to Epstein-Barr virus in patients with rheumatoid arthritis and healthy subjects predisposed to the disease. A twin study","volume":"12","author":"Svendsen","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jcv.2025.105854_bib89","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/j.1749-6632.2009.04808.x","article-title":"The role of infections in the immunopathogensis of systemic sclerosis--evidence from serological studies","volume":"1173","author":"Arnson","year":"2009","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jcv.2025.105854_bib90","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/imm.12200","article-title":"Epstein-Barr virus antibodies mark systemic lupus erythematosus and scleroderma patients negative for anti-DNA","volume":"141","author":"Fattal","year":"2014","journal-title":"Immunology"},{"key":"10.1016\/j.jcv.2025.105854_bib91","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/370516","article-title":"Epstein-Barr virus and systemic lupus erythematosus","volume":"2012","author":"Draborg","year":"2012","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.jcv.2025.105854_bib92","first-page":"44","article-title":"High prevalence of immunoglobulin a antibody against Epstein-Barr virus capsid antigen in adult patients with lupus with disease flare: case control studies","volume":"32","author":"Chen","year":"2005","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jcv.2025.105854_bib93","first-page":"866","article-title":"Epstein-Barr virus infection in peripheral blood mononuclear cells, synovial fluid cells, and synovial membranes of patients with rheumatoid arthritis","volume":"27","author":"Blaschke","year":"2000","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jcv.2025.105854_bib94","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00430-004-0230-5","article-title":"Detecting Epstein-Barr virus DNA from peripheral blood mononuclear cells in adult patients with systemic lupus erythematosus in Taiwan","volume":"194","author":"Yu","year":"2005","journal-title":"Med. Microbiol. Immunol."},{"key":"10.1016\/j.jcv.2025.105854_bib95","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.651013","article-title":"Innate immune modulation induced by EBV lytic infection promotes endothelial cell inflammation and vascular injury in scleroderma","volume":"12","author":"Farina","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jcv.2025.105854_bib96","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1056\/NEJM198111193052102","article-title":"Defective EBV-specific suppressor T-cell function in rheumatoid arthritis","volume":"305","author":"Tosato","year":"1981","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jcv.2025.105854_bib97","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2014-000015","article-title":"Reduced response to Epstein\u2013Barr virus antigens by T-cells in systemic lupus erythematosus patients","volume":"1","author":"Draborg","year":"2014","journal-title":"Lupus Sci. Med."},{"key":"10.1016\/j.jcv.2025.105854_bib98","first-page":"11","article-title":"Epstein-Barr virus and systemic autoimmune diseases","author":"Houen","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jcv.2025.105854_bib99","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1146\/annurev.mi.27.100173.002213","article-title":"The EB virus","volume":"27","author":"Epstein","year":"1973","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.jcv.2025.105854_bib100","first-page":"171","article-title":"First E.B.V. vaccine trial in humans using recombinant vaccinia virus expressing the major membrane antigen","volume":"84","author":"Gu","year":"1995","journal-title":"Dev. Biol. Stand."},{"key":"10.1016\/j.jcv.2025.105854_bib101","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1128\/JVI.01409-07","article-title":"Phase I trial of a CD8+ T-cell peptide epitope-based vaccine for infectious mononucleosis","volume":"82","author":"Elliott","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.jcv.2025.105854_bib102","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1086\/523813","article-title":"Recombinant gp350 vaccine for infectious mononucleosis: a phase 2, randomized, double-blind, placebo-controlled trial to evaluate the safety, immunogenicity, and efficacy of an Epstein-Barr virus vaccine in healthy young adults","volume":"196","author":"Sokal","year":"2007","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jcv.2025.105854_bib103","doi-asserted-by":"crossref","first-page":"6771","DOI":"10.1016\/j.vaccine.2015.10.024","article-title":"Identification of the critical attribute(s) of EBV gp350 antigen required for elicitation of a neutralizing antibody response in vivo","volume":"33","author":"Servat","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.jcv.2025.105854_bib104","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.cell.2015.07.043","article-title":"Rational design of an Epstein-Barr virus vaccine targeting the receptor-binding site","volume":"162","author":"Kanekiyo","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.jcv.2025.105854_bib105","doi-asserted-by":"crossref","first-page":"5716","DOI":"10.1073\/pnas.74.12.5716","article-title":"Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine","volume":"74","author":"Elion","year":"1977","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jcv.2025.105854_bib106","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1128\/jvi.34.2.560-568.1980","article-title":"Effect of acyclovir [9-(2-hydroxyethoxymethyl)guanine] on Epstein-Barr virus DNA replication","volume":"34","author":"Colby","year":"1980","journal-title":"J. Virol."},{"key":"10.1016\/j.jcv.2025.105854_bib107","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1080\/00365549950164409","article-title":"Acyclovir for treatment of infectious mononucleosis: a meta-analysis","volume":"31","author":"Torre","year":"1999","journal-title":"Scand. J. Infect. Dis."},{"key":"10.1016\/j.jcv.2025.105854_bib108","first-page":"207","article-title":"Comparative bioavailability of acyclovir from oral valacyclovir and acyclovir in patients treated for recurrent genital herpes simplex virus infection","volume":"8","author":"Bras","year":"2001","journal-title":"Can. J. Clin. Pharmacol."},{"key":"10.1016\/j.jcv.2025.105854_bib109","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jcv.2007.02.002","article-title":"A virologic pilot study of valacyclovir for infectious mononucleosis","volume":"39","author":"Balfour","year":"2007","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.jcv.2025.105854_bib110","doi-asserted-by":"crossref","first-page":"12368","DOI":"10.1073\/pnas.2002392117","article-title":"Tenofovir prodrugs potently inhibit Epstein-Barr virus lytic DNA replication by targeting the viral DNA polymerase","volume":"117","author":"Drosu","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653225000964?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653225000964?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T12:46:53Z","timestamp":1772887613000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653225000964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":110,"alternative-id":["S1386653225000964"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2025.105854","relation":{},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epstein-Barr virus (EBV) infection and its sequelae in the immunocompetent host","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcv.2025.105854","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105854"}}